423 related articles for article (PubMed ID: 17439501)
1. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
[TBL] [Abstract][Full Text] [Related]
2. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
3. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough.
Blondeau K; Dupont LJ; Mertens V; Tack J; Sifrim D
Aliment Pharmacol Ther; 2007 Mar; 25(6):723-32. PubMed ID: 17311606
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
5. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
6. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
Vakil N
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
[TBL] [Abstract][Full Text] [Related]
7. Relationship between symptom response and oesophageal acid exposure after medical and surgical treatment for gastro-oesophageal reflux disease.
Jenkinson AD; Kadirkamanathan SS; Scott SM; Yazaki E; Evans DF
Br J Surg; 2004 Nov; 91(11):1460-5. PubMed ID: 15386326
[TBL] [Abstract][Full Text] [Related]
8. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
[TBL] [Abstract][Full Text] [Related]
9. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.
Mainie I; Tutuian R; Agrawal A; Adams D; Castell DO
Br J Surg; 2006 Dec; 93(12):1483-7. PubMed ID: 17051602
[TBL] [Abstract][Full Text] [Related]
10. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.
Gardner JD; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1381-6. PubMed ID: 15606401
[TBL] [Abstract][Full Text] [Related]
11. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
Hirano I
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
[TBL] [Abstract][Full Text] [Related]
12. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring.
Sifrim D; Dupont L; Blondeau K; Zhang X; Tack J; Janssens J
Gut; 2005 Apr; 54(4):449-54. PubMed ID: 15753524
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
14. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
15. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
Tutuian R; Castell DO
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():27-37. PubMed ID: 16939430
[TBL] [Abstract][Full Text] [Related]
16. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease.
Tack J
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():10-6. PubMed ID: 16939428
[TBL] [Abstract][Full Text] [Related]
17. Review article: The measurement of non-acid gastro-oesophageal reflux.
Smout AJ
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():7-12. PubMed ID: 18081643
[TBL] [Abstract][Full Text] [Related]
18. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis.
Blondeau K; Dupont LJ; Mertens V; Verleden G; Malfroot A; Vandenplas Y; Hauser B; Sifrim D
Gut; 2008 Aug; 57(8):1049-55. PubMed ID: 18372497
[TBL] [Abstract][Full Text] [Related]
19. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
Roman S; Serraj I; Damon H; Mion F
Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
[TBL] [Abstract][Full Text] [Related]
20. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects.
Zerbib F; des Varannes SB; Roman S; Pouderoux P; Artigue F; Chaput U; Mion F; Caillol F; Verin E; Bommelaer G; Ducrotté P; Galmiche JP; Sifrim D
Aliment Pharmacol Ther; 2005 Nov; 22(10):1011-21. PubMed ID: 16268977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
